Literature DB >> 2846560

Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites.

L Antkiewicz-Michaluk1, A G Mukhin, A Guidotti, K E Krueger.   

Abstract

The photoaffinity ligand [3H]PK 14105 was utilized to modify covalently peripheral-type benzodiazepine binding sites in rat adrenal mitochondrial preparations. The photolabeled membrane preparations were then solubilized in 1% digitonin and the detergent-soluble extracts subjected to fractionation by ion-exchange chromatography and reversed-phase high performance liquid chromatography. This scheme resulted in the purification of the putative binding site protein for PK 14105 which we have entitled PKBS. Purified preparations of PKBS exhibited a single band with a Mr of approximately 17,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver-staining or autoradiographic detection. Additional criteria examining the purity of PKBS preparations were provided by radioiodination with Bolton-Hunter reagent, amino acid analysis, gas-phase sequencing, and reversed-phase chromatography suggesting that this protein was purified to apparent homogeneity. These results demonstrate that a protein associated with peripheral-type benzodiazepine recognition sites has been isolated thus facilitating more direct studies on the structure of this receptor and on the role of these binding sites in mediating responses elicited by benzodiazepines acting at these sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846560

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The peripheral benzodiazepine receptors: a review.

Authors:  A Beurdeley-Thomas; L Miccoli; S Oudard; B Dutrillaux; M F Poupon
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Immunological studies on the rat peripheral-type benzodiazepine acceptor.

Authors:  P N Moynagh; C J Bailey; S J Boyce; D C Williams
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 3.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 4.  Molecular mechanisms of peripheral benzodiazepine receptors.

Authors:  S H Snyder; M W McEnery; A Verma
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 5.  The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC).

Authors:  M W McEnery
Journal:  J Bioenerg Biomembr       Date:  1992-02       Impact factor: 2.945

6.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier.

Authors:  M W McEnery; A M Snowman; R R Trifiletti; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 7.  The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing.

Authors:  Priya Singh; Anupriya Adhikari; Deepika Singh; Chandraprakash Gond; Anjani Kumar Tiwari
Journal:  ACS Omega       Date:  2022-04-18

8.  Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues.

Authors:  Kanako Morohaku; Newton S Phuong; Vimal Selvaraj
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

9.  TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.

Authors:  Danielle A Simmons; Michelle L James; Nadia P Belichenko; Sarah Semaan; Christina Condon; Jason Kuan; Adam J Shuhendler; Zheng Miao; Frederick T Chin; Frank M Longo
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

Review 10.  Cellular sources of TSPO expression in healthy and diseased brain.

Authors:  Erik Nutma; Kelly Ceyzériat; Sandra Amor; Stergios Tsartsalis; Philippe Millet; David R Owen; Vassilios Papadopoulos; Benjamin B Tournier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-12       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.